Saturday 17 October 2026
Export NGVT’s income statement to Excel — free account
Ingevity Corporation
NGVT Basic Materials Specialty Chemicals
In the quarter to June 2026, revenue fell 5.25%, EPS grew 125.4%, free cash flow fell 136.1% and total debt fell 14.5%, each against the same quarter a year earlier.
69.82
0.72
−1.02%
Follow NGVT
| Dec '25 | Dec '24 | Dec '23 | Dec '22 | Dec '21 | Dec '20 | Dec '19 | Dec '18 | Dec '17 | Dec '16 | |
|---|---|---|---|---|---|---|---|---|---|---|
P/E ratio |
0.00 | 0.00 | 0.00 | 12.87 | 24.31 | 16.79 | 19.95 | 20.77 | 23.72 | 66.48 |
Piotroski F-Score |
6 | 6 | 5 | 6 | 5 | 7 | 5 | 6 | 7 | 4 |
P/S ratio |
1.84 | 1.23 | 1.41 | 1.63 | 2.05 | 2.57 | 2.83 | 3.10 | 3.07 | 2.47 |
Altman Z-Score |
1.84 | 1.54 | 1.91 | 2.47 | 2.58 | 2.63 | 2.84 | 4.21 | 4.95 | 3.73 |
P/FCF ratio |
7.74 | 29.02 | 17.99 | 15.87 | 15.06 | 11.58 | 22.70 | 22.25 | 24.55 | 31.45 |
Altman Z″-Score (non-manufacturers) |
1.09 | 1.64 | 2.83 | 3.26 | 3.45 | 3.27 | 2.71 | 3.63 | 3.85 | 2.33 |
Beneish M-Score |
(4.00) | (3.50) | (2.88) | (2.24) | (2.72) | (2.87) | (2.20) | (2.21) | (2.56) | (3.22) |
P/Operating CF |
22.08 | 22.95 | 37.11 | 27.53 | 37.42 | 20.42 | 42.72 | 41.10 | 73.40 | 41.62 |
P/B ratio |
72.18 | 7.58 | 2.72 | 3.88 | 4.24 | 4.87 | 6.88 | 10.39 | 10.75 | 16.64 |
Price to Tangible BV |
0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 42.70 | 11.46 | 19.49 |
EV/Sales |
2.78 | 2.31 | 2.48 | 2.47 | 2.77 | 3.42 | 3.75 | 3.71 | 3.45 | 2.97 |
EV/EBITDA |
13.18 | 6.68 | 9.33 | 9.57 | 9.61 | 11.14 | 13.62 | 13.57 | 14.48 | 19.20 |
EV/Operating CF |
9.80 | 21.54 | 14.73 | 13.17 | 13.12 | 11.80 | 17.57 | 16.67 | 19.24 | 21.09 |
EV/FCF |
11.71 | 54.33 | 31.69 | 24.14 | 20.31 | 15.38 | 30.10 | 26.57 | 27.55 | 37.89 |
Quick Ratio |
0.60 | 0.76 | 0.77 | 0.99 | 1.63 | 1.82 | 0.96 | 1.07 | 1.23 | 0.88 |
Current Ratio |
1.33 | 1.87 | 1.81 | 2.25 | 2.70 | 2.81 | 2.15 | 2.31 | 2.41 | 2.16 |
Net Debt/EBITDA |
4.40 | 3.07 | 3.98 | 3.24 | 2.43 | 2.70 | 3.30 | 2.14 | 1.58 | 3.26 |
Debt/Assets |
70.34% | 66.24% | 52.71% | 53.81% | 50.63% | 54.29% | 57.36% | 56.36% | 48.77% | 58.69% |
Debt/Equity |
39.10 | 6.86 | 2.19 | 2.11 | 1.86 | 1.97 | 2.31 | 2.19 | 1.63 | 3.63 |
Asset Turnover |
0.64 | 0.52 | 0.45 | 0.64 | 0.58 | 0.54 | 0.75 | 1.01 | 1.10 | 1.13 |
Operating CF/Net income |
(1.98) | (0.30) | (37.98) | 1.48 | 0.00 | 1.94 | 1.50 | 1.49 | 1.38 | 3.63 |
Capex/Depreciation |
(0.19) | (0.17) | (0.89) | (1.31) | (0.94) | (0.82) | (1.35) | (1.65) | (1.30) | (1.46) |
Interest Coverage |
(0.56) | (0.43) | 2.15 | 5.21 | 5.62 | 5.80 | 4.95 | 7.61 | 10.56 | 5.27 |
| (148.60%) | (104.11%) | (0.81%) | 30.84% | 0.00% | 30.93% | 42.25% | 54.85% | 61.33% | 10.80% | |
| (9.10%) | (18.52%) | (0.20%) | 8.13% | 0.00% | 8.11% | 10.63% | 15.07% | 14.36% | 4.37% | |
ROIC |
(2.47%) | (1.81%) | 6.54% | 9.62% | 11.01% | 10.34% | 9.93% | 15.75% | 18.56% | 10.72% |
Return on Tangible Assets |
(23.18%) | (49.35%) | (0.51%) | 17.96% | 0.00% | 16.36% | 20.13% | 22.16% | 19.34% | 6.06% |
Average Days of Receivables |
39.76 | 40.06 | 54.65 | 49.18 | 42.42 | 44.42 | 42.35 | 38.28 | 37.54 | 36.09 |
Research and Development Expense of Revenue |
2.43% | 2.04% | 2.09% | 1.82% | 1.89% | 1.86% | 1.52% | 1.90% | 2.04% | 1.94% |
Selling, General and Administrative Expense of Revenue |
14.66% | 13.15% | 13.31% | 11.92% | 12.89% | 12.29% | 12.62% | 11.68% | 10.94% | 10.61% |
Intangible Assets out of Total Assets |
0.11 | 0.22 | 0.33 | 0.34 | 0.32 | 0.35 | 0.39 | 0.19 | 0.02 | 0.02 |
Share Based Compensation of Revenue |
1.57% | 0.99% | 0.87% | 0.97% | 0.88% | 0.69% | 0.95% | 1.10% | 1.04% | 0.52% |
Graham Net Nets |
(0.54) | (0.90) | (0.78) | (0.50) | (0.37) | (0.34) | (0.31) | (0.16) | (0.09) | (0.18) |
Graham Number |
0.00 | 0.00 | 0.00 | 47.66 | 33.52 | 39.71 | 35.38 | 27.03 | 21.07 | 7.59 |
Earnings Yield |
(7.82%) | (29.06%) | (0.40%) | 7.77% | 4.11% | 5.96% | 5.01% | 4.82% | 4.22% | 1.50% |
Free Cash Flow Yield |
12.93% | 3.45% | 5.56% | 6.30% | 6.64% | 8.64% | 4.41% | 4.49% | 4.07% | 3.18% |
Revenue per Share |
32.23 | 33.04 | 33.31 | 43.70 | 34.95 | 29.42 | 30.93 | 26.97 | 23.08 | 21.57 |
Operating CF per Share |
9.14 | 3.54 | 5.62 | 8.21 | 7.37 | 8.53 | 6.60 | 5.99 | 4.14 | 3.04 |
Capex per Share |
(1.49) | (2.14) | (3.01) | (3.73) | (2.61) | (1.99) | (2.75) | (2.23) | (1.25) | (1.35) |
Free Cash Flow per Share |
7.65 | 1.40 | 2.61 | 4.48 | 4.76 | 6.54 | 3.85 | 3.76 | 2.89 | 1.69 |
Cash per Share |
2.16 | 1.87 | 2.63 | 2.01 | 6.92 | 6.24 | 1.35 | 1.84 | 2.09 | 0.72 |
Shareholders Equity per Share |
0.82 | 5.37 | 17.30 | 18.29 | 16.92 | 15.54 | 12.70 | 8.06 | 6.60 | 3.20 |
Interest Debt per Share |
0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
Book value per Share |
0.82 | 5.37 | 17.30 | 18.29 | 16.92 | 15.54 | 12.70 | 8.06 | 6.60 | 3.20 |
Free Cash Flow |
277.10 | 51.00 | 95.30 | 170.90 | 189.50 | 270.30 | 160.90 | 158.10 | 121.70 | 71.20 |
Working Capital |
112.90 | 229.10 | 295.70 | 379.80 | 456.00 | 405.30 | 247.70 | 239.40 | 215.50 | 158.30 |
Capital Expenditures |
(54.10) | (77.60) | (109.80) | (142.50) | (103.80) | (82.10) | (114.80) | (93.90) | (52.60) | (56.70) |
Net Current Asset Value |
(1,167.20) | (1,334.20) | (1,333.30) | (1,354.90) | (1,070.30) | (1,063.70) | (1,147.70) | (553.80) | (283.00) | (403.00) |
EV/EBIT |
0.00 | 0.00 | 15.04 | 12.81 | 13.25 | 15.22 | 17.90 | 16.63 | 17.55 | 26.53 |
Capex to Sales |
0.05 | 0.06 | 0.09 | 0.09 | 0.07 | 0.07 | 0.09 | 0.08 | 0.05 | 0.06 |
Price to Operating Income |
0.00 | 0.00 | 8.54 | 8.42 | 9.83 | 11.46 | 13.50 | 13.93 | 15.63 | 22.02 |
| Other line items | ||||||||||
Depreciation/Fixed assets |
0.48 | 0.71 | 0.16 | 0.14 | 0.15 | 0.14 | 0.13 | 0.11 | 0.09 | 0.09 |
Cash ROIC |
21.83% | 3.18% | 4.52% | 7.60% | 8.62% | 12.47% | 8.86% | 13.66% | 14.86% | 10.89% |
Accounts Receivable Turnover |
9.02 | 7.65 | 5.98 | 8.63 | 8.99 | 8.16 | 9.62 | 10.36 | 10.25 | 9.82 |
Accounts Payable Turnover |
7.57 | 5.81 | 4.62 | 7.31 | 7.64 | 7.38 | 8.45 | 8.15 | 7.93 | 8.80 |
Inventory Turnover |
3.70 | 2.91 | 2.39 | 3.81 | 4.09 | 3.74 | 4.02 | 4.08 | 4.14 | 4.22 |
Average Days of Payables |
47.56 | 46.91 | 75.04 | 58.10 | 52.26 | 50.67 | 44.61 | 47.31 | 47.14 | 45.60 |
Days of Inventory on Hand |
96.15 | 97.24 | 146.28 | 111.34 | 100.19 | 91.91 | 95.65 | 97.46 | 90.77 | 87.06 |
Average Receivables |
129.45 | 156.85 | 203.40 | 193.25 | 154.85 | 149.00 | 134.45 | 109.45 | 94.90 | 92.50 |
Average Payables |
93.25 | 126.45 | 166.60 | 150.30 | 115.00 | 101.65 | 96.00 | 88.00 | 81.15 | 72.00 |
Average Inventory |
190.95 | 252.35 | 321.90 | 288.10 | 215.10 | 200.75 | 201.95 | 175.70 | 155.60 | 150.05 |
Average Assets |
1,836.85 | 2,322.95 | 2,679.90 | 2,602.75 | 2,401.75 | 2,238.10 | 1,728.45 | 1,122.40 | 881.20 | 805.75 |
Average Common Equity |
112.45 | 413.30 | 664.85 | 686.05 | 657.95 | 586.45 | 434.75 | 308.30 | 206.25 | 326.00 |
Columns are period end dates